Pathfinder Cell Therapy Inc

PINK:PFND USA Biotechnology
Market Cap
$66.72K
Market Cap Rank
#51177 Global
#15860 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.02
About

Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies… Read more

Pathfinder Cell Therapy Inc (PFND) - Total Liabilities

Latest total liabilities as of September 2015: $6.77 Million USD

Based on the latest financial reports, Pathfinder Cell Therapy Inc (PFND) has total liabilities worth $6.77 Million USD as of September 2015.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Pathfinder Cell Therapy Inc - Total Liabilities Trend (1999–2014)

This chart illustrates how Pathfinder Cell Therapy Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Pathfinder Cell Therapy Inc Competitors by Total Liabilities

The table below lists competitors of Pathfinder Cell Therapy Inc ranked by their total liabilities.

Liability Composition Analysis (1999–2014)

This chart breaks down Pathfinder Cell Therapy Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.00 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.01 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 173.56 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pathfinder Cell Therapy Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pathfinder Cell Therapy Inc (1999–2014)

The table below shows the annual total liabilities of Pathfinder Cell Therapy Inc from 1999 to 2014.

Year Total Liabilities Change
2014-12-31 $6.05 Million +28.54%
2013-12-31 $4.71 Million +46.74%
2012-12-31 $3.21 Million +137.38%
2011-12-31 $1.35 Million +20.84%
2010-12-31 $1.12 Million +194.99%
2009-12-31 $379.00K -11.45%
2008-12-31 $428.00K -23.02%
2007-12-31 $556.00K -34.67%
2006-12-31 $851.00K -10.98%
2005-12-31 $956.00K +21.94%
2004-12-31 $784.00K -21.29%
2003-12-31 $996.00K -12.94%
2002-12-31 $1.14 Million -36.09%
2001-12-31 $1.79 Million +1.42%
2000-12-31 $1.76 Million -1.34%
1999-12-31 $1.79 Million --